Akademik Veri Yönetim Sistemi
Journal of Oral and Maxillofacial Surgery, cilt.82, sa.3, ss.279-287, 2024 (SCI-Expanded)
Background: Postoperative nausea and vomiting (PONV) is a common adverse side-effect following orthognathic surgery, with pain potentially contributing as a risk factor. Purpose: The study's purpose was to measure the association between postoperative pain and PONV. Study Design, Setting, Sample: This prospective cohort study involved patients who underwent bimaxillary surgery at Erciyes University, Oral and Maxillofacial Surgery Hospital. Patients with a history of routine antiemetic use, pregnancy, breastfeeding, morbid obesity, cardiac dysrhythmia, mental retardation, or psychiatric illness were excluded. Predictor/Exposure/Independent Variable: The predictor variable was postoperative pain, which was measured using a 100-mm visual analogue scale (VAS). VAS scores were documented at the 30-minute postoperative mark (referred to as VAS1), and the mean of hourly VAS scores over the initial three postoperative hours (denoted as VAS2). Main Outcome Variable(s): The primary outcome was the occurrence of PONV, defined as active vomiting, retching, or nausea leading to vomiting. The secondary outcome was the timing of PONV, categorized as early (within 6 hours), late (6-24 hours), and delayed (beyond 24 hours postoperatively). Covariates: The study's covariates were age, sex, body mass index, Apfel risk scores, surgery duration, history of PONV or motion sickness, and smoking status. Analyses: Descriptive statistics and χ2 tests were used for data analysis, with statistical significance set at P value <.05. Results: The sample was composed of 86 subjects with a median age of 20 years (range: 18-30 years), of which 37.2% were male. The frequency of PONV was 50%. Postoperative pain, as measured by VAS scores, was significantly higher in the PONV group compared to the non-PONV group. The median VAS1 score was 60.0 (PONV group, range 40–90) versus 50.0 (non-PONV, range 0–90) (P =.041); for VAS2, it was 60.0 (PONV, range 40–80) compared to 40.0 (non-PONV, range 30–60) (P <.001). Conclusions and Relevance: The frequency of PONV observed in patients undergoing bimaxillary surgery is substantial, necessitating the identification and management of risk factors to enhance perioperative care and patient outcomes. By improving PONV management and addressing postoperative pain, health-care providers can enhance the perioperative experience and patient outcomes in bimaxillary surgery.